Biosimilars in Rheumatoid Arthritis: Current and Emerging Opportunities to Optimize Care
WebcastOVERVIEW
Biosimilars in Rheumatoid Arthritis: Current and Emerging Opportunities to Optimize Care is organized by North American Center for Continuing Medical Education (NACCME) and will be held from Dec 11, 2017 - Dec 11, 2018. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Course Objectives:
• Explain the impact of biosimilars on expenditures, accessibility, and the care of patients with rheumatoid arthritis (RA)
• Describe clinical data required for the approval of biosimilars in RA
• Highlight recent biosimilar advances, approvals, and data supporting the safety, efficacy, and biosimilarity to respective reference biologics
• Incorporate new and emerging biosimilars into individualized RA treatment plans
Additional details will be posted as soon as they are available.
Course Objectives:
• Explain the impact of biosimilars on expenditures, accessibility, and the care of patients with rheumatoid arthritis (RA)
• Describe clinical data required for the approval of biosimilars in RA
• Highlight recent biosimilar advances, approvals, and data supporting the safety, efficacy, and biosimilarity to respective reference biologics
• Incorporate new and emerging biosimilars into individualized RA treatment plans
Additional details will be posted as soon as they are available.
SPECIALITIES
RheumatologyRELATED ONLINE COURSES
Quick Links